Hyosung Chemical Discloses Corporate Governance Report: No Dividends and Partial Non-Compliance Pose Challenges to Shareholder Value Enhancement
Hyosung Chemical disclosed its corporate governance report: largest shareholder (Hyosung Group and 12 others) holds 52.32%, minority shareholders 47.68%.
No dividends paid for the past three consecutive years (2023-2025); no formalized dividend policy or mid-to-long-term shareholder return policy in place.
Board comprises 2 inside and 3 outside directors (all male); outside director ratio at 60% meets legal requirements; audit committee consists entirely of 3 outside directors.
Key governance indicators partially non-compliant: AGM notice not given 4 weeks in advance, no electronic voting, no dividend predictability, single-gender board, cumulative voting excluded.
Significant related-party transactions with the largest shareholder and affiliates; in 2025, business transfer (tank terminal division, KRW 150B) and continued financial support and collateral provision.
Consolidated operating losses for three consecutive years (KRW -160.5B, -174.8B, -217.8B), but net profit of KRW 326.0B in 2025 (likely due to one-off gains from business transfer).
No individual evaluation process for outside directors nor reflection in reappointment; no separate meetings exclusively for outside directors held.
CEO succession policy not documented; only internal processes in operation.
Issued 5th convertible bonds worth KRW 100B in December 2025 (conversion price KRW 38,900), creating potential dilution risk.
[AI Comprehensive Analysis]Hyosung Chemical's governance largely meets legal minimums, but lack of shareholder returns, low governance compliance, and insufficient minority shareholder protection are negative factors for shareholder value. Future dividend policy establishment and governance improvement efforts will be key variables for the stock price.